Immunovia publ AB Working Capital to Net Assets Ratio
Immunovia publ AB working capital to net assets ratio. Immunovia publ AB (IMMNOV) has a Working Capital to Net Assets ratio of 58.9% as of June 2026. Working capital of Skr13.92 Million (current assets of Skr38.32 Million minus current liabilities of Skr24.40 Million) is measured against net assets of Skr23.64 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Immunovia publ AB (2012–2025)
Working capital to net assets ratio of Immunovia publ AB from 2012 to 2025. This chart shows how Immunovia publ AB's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 58.9%, reflecting working capital of Skr13.92 Million against net assets of Skr23.64 Million SEK. See IMMNOV cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Immunovia publ AB Working Capital to Net Assets Ratio by Year (2012–2025)
Immunovia publ AB working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Immunovia publ AB from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Immunovia publ AB.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.0% | Skr64.71 Million | Skr64.73 Million | Skr80.41 Million | Skr15.69 Million | ▲ +38.1 pp |
| 2024 | 61.8% | Skr7.20 Million | Skr11.65 Million | Skr28.59 Million | Skr21.39 Million | ▼ -13.7 pp |
| 2023 | 75.5% | Skr50.61 Million | Skr66.99 Million | Skr80.51 Million | Skr29.90 Million | ▲ +38.0 pp |
| 2022 | 37.5% | Skr91.53 Million | Skr243.80 Million | Skr115.61 Million | Skr24.09 Million | ▼ -23.4 pp |
| 2021 | 60.9% | Skr264.35 Million | Skr433.90 Million | Skr297.10 Million | Skr32.75 Million | ▼ -12.7 pp |
| 2020 | 73.6% | Skr441.01 Million | Skr599.40 Million | Skr474.80 Million | Skr33.79 Million | ▲ +6.3 pp |
| 2019 | 67.3% | Skr240.52 Million | Skr357.61 Million | Skr269.16 Million | Skr28.64 Million | ▼ -15.7 pp |
| 2018 | 82.9% | Skr383.14 Million | Skr461.95 Million | Skr398.57 Million | Skr15.43 Million | ▲ +2.7 pp |
| 2017 | 80.3% | Skr190.03 Million | Skr236.80 Million | Skr204.01 Million | Skr13.97 Million | ▼ -11.6 pp |
| 2016 | 91.9% | Skr254.15 Million | Skr276.63 Million | Skr260.92 Million | Skr6.78 Million | ▲ +9.2 pp |
| 2015 | 82.6% | Skr69.24 Million | Skr83.80 Million | Skr76.95 Million | Skr7.71 Million | ▲ +0.0 pp |
| 2014 | 82.6% | Skr29.53 Million | Skr35.74 Million | Skr32.66 Million | Skr3.13 Million | ▲ +55.4 pp |
| 2013 | 27.2% | Skr1.34 Million | Skr4.94 Million | Skr3.87 Million | Skr2.53 Million | ▲ +94.2 pp |
| 2012 | -67.0% | Skr-888.33K | Skr1.33 Million | Skr783.30K | Skr1.67 Million | — |